Alignment Healthcare Azioni (NASDAQ: ALHC)

Ultime notizie per Alignment Healthcare (NASDAQ:ALHC) Azioni

Alignment Healthcare

Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.

Alignment Healthcare, Inc. - Common Stock

Alignment Healthcare Inc

Susquehanna analyst Charles Minervino maintains RTX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) with a Positive and lowers the price target from $150 to $139.

News

Price Target

Analyst Ratings

Susquehanna Maintains Positive on RTX, Lowers Price Target to $139

According to Robb Report, the Beverly Hills residence of the late Brian Goldner, the former Hasbro chairman and CEO who transformed the toy giant into an entertainment powerhouse, is on the market for $27 million.
Goldner, who died of cancer in 2021 at age 58 and his wife Barbara acquired the 1980s-era home in 2020 for about $18 million.
Renowned interior designer Michael S. Smith, known for his work on the Obama White House, reimagined the traditional-style home. The residence spans nearly 7,500 square feet across two levels and has five bedrooms, eight bathrooms and luxurious living spaces.
Don't Miss:
<ul>
<li>Unlock the hidden potential of commercial real estate —<a href="https://equitymultiple.com/benzinga?invite=benzinga&amp;utm_campaign=product-promotion-earn&amp;utm_source=yahooFinance&amp;utm_medium=affiliate&amp;utm_content=unlockboost-yahoo"> This platform allows individuals to invest in commercial real estate offering a 12% target yield with a bonus 1% return boost today!</a></li>
<li>This Jeff Bezos-backed startup will allow you to <a href="https://arrivedhomes.go2cloud.org/aff_c?offer_id=15&amp;aff_id=1006&amp;aff_sub=yahoo&amp;aff_sub2=byerscta100">become a landlord in just 10 minutes, with minimum investments as low as $100 for properties like the Byer House from Stranger Things.</a></li>
</ul>
Antonio Bruno of Sotheby's International Realty-Beverly Hills Brokerage and Tomer Fridman of Christie's International Real Estate handle the listing.
The secluded estate, nestled in the coveted Flats neighborhood, sits on nearly half an acre of manicured grounds, fully enclosed by walls and gates. A sage-green front door beckons entry into the residence, featuring a mansard roof and a striking façade of white brick and stucco.
The grand entrance's double-height foyer is adorned with a sweeping iron-railed staircase that ascends toward a sky-lit ceiling.
See Also: During market downturns, investors are learning that unlike equities, these<a href="https://www.benzinga.com/money/connect-invest-real-estate-notes-y2"> high-yield real estate notes that pay 7.5% &#8211; 9% are protected by resilient assets, buffering against losses.</a>
The living room&#8217;s centerpiece is a veined-marble fireplace and the gourmet kitchen features a central island, a high-end Caliber range and a cozy breakfast nook. A wood-paneled office provides a dedicated workspace and the large primary suite includes a fireplace, a separate office and dual baths.
The outdoor oasis features a lush, hedge-lined backyard with a pool, spa and Baja shelf. A built-in barbecue and fireplace in a pergola-shaded lounge area create a perfect setting for outdoor entertaining. A versatile guesthouse/cabana is currently used as a home gym.
As first reported by Mansion Global, the Goldner family is relocating outside of California. Barbara Goldner, a clinical social worker, also owns property in Rhode Island.
Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl-y2"> you can become an investor for $0.80 per share today.</a>
Brian Goldner, a visionary leader in the<a href="https://www.benzinga.com/money/best-toys-to-collect-for-investment"> toy industry</a>, joined<a href="https://www.benzinga.com/quote/HAS"> Hasbro</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAS#NASDAQ">HAS</a>) in 2000 and rapidly ascended to the CEO position in 2008 and board chairman in 2015. Under his leadership, Hasbro evolved from a traditional toy company into a global leader in play and entertainment.
Goldner spearheaded a strategic vision to create world-class play and storytelling experiences, expanding the company's reach beyond toys and games into television, movies, digital gaming and other entertainment sectors. The transformative strategy culminated in the 2019 acquisition of eOne, an independent entertainment studio.
Goldner also served on the ViacomCBS board of directors and chaired its compensation committee.
Read Next:
<ul>
<li>Commercial real estate has historically outperformed the stock market, and<a href="https://equitymultiple.com/benzinga?invite=benzinga&amp;utm_campaign=product-promotion-earn&amp;utm_source=yahooFinance&amp;utm_medium=affiliate&amp;utm_content=stockmarket-yahoo"> this platform allows individuals to invest in commercial real estate with as little as $5,000 offering a 12% target yield with a bonus 1% return boost today!</a></li>
<li><a href="https://www.benzinga.com/go/arrived-private-credit-yf">Arrived Home's Private Credit Fund&#8217;s has historically paid an annualized dividend yield of 8.1%&#x2A;</a>, which provides access to a pool of short-term loans backed by residential real estate with just a $100 minimum.<a href="https://www.benzinga.com/go/arrived-private-credit-yf"> </a></li>
</ul>

Real Estate

$27 Million Price Tag For Late Hasbro CEO's Beverly Hills Oasis

BlackRock, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) will release earnings results for its fourth quarter, before the opening <a href="https://www.benzinga.com/quote/BLK/earnings">bell on Wednesday, Jan. 15, 2025.</a>
Analysts expect the company to report quarterly earnings at $11.38 per share, up from $9.66 per share in the year-ago period. BlackRock projects to report revenue of $5.63 billion for the recent quarter, compared to $4.63 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Dec. 3, the company disclosed a definitive agreement to acquire HPS Investment Partners for around $12 billion.
BlackRock shares fell 3.2% to close at $980.76 on Tuesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Rating</a>s page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/BLK/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Wells Fargo analyst Michael Brown maintained an Overweight rating and slashed the price target from $1,200 to $1,155 on Jan. 7, 2025. This analyst has an accuracy rate of 70%.</li>
<li>Citigroup analyst William Katz maintained a Buy rating and boosted the price target from $1,150 to $1,200 on Dec. 23, 2024. This analyst has an accuracy rate of 67%.</li>
<li>Morgan Stanley analyst Mike Cyprys maintained an Overweight rating and raised the price target from $1,245 to $1,261 on Dec. 20, 2024. This analyst has an accuracy rate of 63%.</li>
<li>Barclays analyst Benjamin Budish maintained an Overweight rating and raised the price target from $1,120 to $1,220 on Dec. 9, 2024. This analyst has an accuracy rate of 81%.</li>
<li>Evercore ISI Group analyst Glenn Schorr maintained an Outperform rating and raised the price target from $1,040 to $1,160 on Nov. 7, 2024. This analyst has an accuracy rate of 77%.</li>
</ul>
Considering buying BLK stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="580" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08033901/image-37-1024x580.png" alt="" class="wp-image-723356" style="width:576px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08033901/image-37-1024x580.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08033901/image-37-300x170.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08033901/image-37-768x435.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08033901/image-37.png 1132w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next:<a href="https://www.benzinga.com/analyst-ratings/price-target/25/01/42846607/bank-of-new-york-mellon-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call"> </a>
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/01/42846607/bank-of-new-york-mellon-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call">Bank of New York Mellon Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a></li>
</ul>

Earnings

Markets

Trading Ideas

BlackRock Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Susquehanna analyst Bascome Majors maintains Norfolk Southern (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSC#NYSE">NSC</a>) with a Neutral and lowers the price target from $285 to $265.

Susquehanna Maintains Neutral on Norfolk Southern, Lowers Price Target to $265

CGBS

Crown LNG Shares Halted On Circuit Breaker To The Downside, Stock Now Up 39.6%

Wells Fargo analyst Michael Blum maintains First Solar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>) with a Overweight and lowers the price target from $240 to $209.

FSLR

Wells Fargo Maintains Overweight on First Solar, Lowers Price Target to $209

Susquehanna analyst Charles Minervino maintains Northrop Grumman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOC#NYSE">NOC</a>) with a Positive and lowers the price target from $625 to $557.

Susquehanna Maintains Positive on Northrop Grumman, Lowers Price Target to $557

LRHC

La Rosa Holdings Shares Resume Trade

BFRI

Biofrontera Shares Resume Trading

Wells Fargo analyst Praneeth Satish maintains Enphase Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) with a Overweight and lowers the price target from $101 to $83.

ENPH

Wells Fargo Maintains Overweight on Enphase Energy, Lowers Price Target to $83

Susquehanna analyst Charles Minervino maintains Lockheed Martin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) with a Positive and lowers the price target from $695 to $590.

Susquehanna Maintains Positive on Lockheed Martin, Lowers Price Target to $590

Amplify ETFs, a leading provider of exchange traded funds, today announced the scheduled liquidation of the Amplify U.S. Alternative Harvest ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MJUS#NYSE">MJUS</a>) (the "Fund").
Based on the recommendation of Amplify Investments LLC, the Fund's investment adviser, the Board of Trustees of the Amplify ETF Trust unanimously determined that it is in the best interests of the Fund and its shareholders to liquidate the Fund.
The Fund will no longer accept creation orders after the close of business on January 20, 2025. Shareholders may sell their shares in the Fund prior to the end of trading on January 27, 2025. Customary brokerage charges may apply to these transactions. The Fund will cease trading at the end of the trading day on January 27, 2025.
The Fund will be liquidated and a final distribution to shareholders of the Fund is expected to occur on or around January 30, 2025. Any person holding shares in the Fund as of the liquidation date will receive a cash redemption amount equal to the net asset value of their shares as of that date. Shareholders will generally recognize a capital gain or loss on any redemption.

MJUS

Reported Earlier, Amplify ETFs To Liquidate The Amplify U.S. Alternative Harvest ETF; The Fund Will No Longer Accept Creation Orders After The Close Of Business On January 20, 2025. Shareholders May Sell Their Shares In The Fund Prior To The End Of Trading On January 27, 2025; Liquidated And A Final Distribution To Shareholders Of The Fund Is Expected To Occur On Or Around January 30, 2025

Wells Fargo analyst Michael Blum maintains Canadian Solar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSIQ#NASDAQ">CSIQ</a>) with a Equal-Weight and lowers the price target from $13 to $10.

CSIQ

Wells Fargo Maintains Equal-Weight on Canadian Solar, Lowers Price Target to $10

WIIM

AMD shares are trading lower after HSBC downgraded the stock from Buy to Reduce and lowered its price target from $200 to $110.

Susquehanna analyst Charles Minervino maintains L3Harris Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LHX#NYSE">LHX</a>) with a Positive and lowers the price target from $300 to $258.

Susquehanna Maintains Positive on L3Harris Technologies, Lowers Price Target to $258

Wells Fargo analyst Michael Blum maintains Array Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARRY#NASDAQ">ARRY</a>) with a Equal-Weight and lowers the price target from $8 to $7.

ARRY

Wells Fargo Maintains Equal-Weight on Array Technologies, Lowers Price Target to $7

XChange TEC.INC Shares Resume Trade

Biofrontera Shares Halted On Circuit Breaker To The Downside, Stock Now Up 20.7%

UBS analyst Eliana Merle maintains Revolution Medicines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVMD#NASDAQ">RVMD</a>) with a Buy and raises the price target from $65 to $71.

RVMD

UBS Maintains Buy on Revolution Medicines, Raises Price Target to $71

U.S. stocks were lower, with the Dow Jones index falling over 150 points on Wednesday.
Shares of AAR Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIR#NYSE">AIR</a>) rose sharply during Tuesday's session after posted stronger-than-expected <a href="https://www.benzinga.com/news/earnings/25/01/42862022/aar-shares-climb-on-better-than-expected-q2-results-details">second-quarter results.</a>
The company reported quarterly earnings of 90 cents per share, which beat the analyst consensus estimate of 84 cents. Quarterly revenue came in at $686.1 million, which beat the analyst consensus estimate of $654.18 million.
AAR shares jumped 9.6% to $67.67 on Wednesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Sana Biotechnology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANA#NASDAQ">SANA</a>) shares jumped 249% to $5.77 after the company on Tuesday announced clinical trial results from its type 1 diabetes study of islet cell transplantation without immunosuppression.</li>
<li>Vir Biotechnology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIR#NASDAQ">VIR</a>) gained 64% to $12.97 after the company announced it&#8217;s presenting initial Phase 1 data from its two dual-masked T-cell engagers (TCEs): VIR-5818 and VIR-5500.</li>
<li>AngioDynamics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGO#NASDAQ">ANGO</a>) surged 25% to $11.74 after the company reported better-than-expected second-quarter financial results and raised its FY25 adjusted EPS guidance.</li>
<li>Absci Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABSI#NASDAQ">ABSI</a>) rose 17% to $3.5900 after the company announced a strategic collaboration with AMD.</li>
<li>eBay Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBAY#NASDAQ">EBAY</a>) surged 11.5% to $70.44 after Meta announced a test in Germany, France and the US that will allow buyers to browse eBay listings directly on Facebook Marketplace.</li>
<li>Matthews International Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MATW#NASDAQ">MATW</a>) gained 10.2% to $29.87 as the company agreed to sell SGK Brand Solutions.</li>
<li>Arcadium Lithium plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALTM#NASDAQ">ALTM</a>) rose 8.6% to $5.72 after the company announced it secured CFIUS clearance regarding Rio Tinto&#8217;s proposed acquisition.</li>
<li>Cal-Maine Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) gained 7.1% to $111.00 as the company posted better-than-expected results for its second quarter. The company said it set a quarterly record for total dozens sold and specialty dozens sold. It also announced a cash dividend of approximately $1.49 per share.</li>
<li>ADTRAN Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADTN#NASDAQ">ADTN</a>) rose 6.3% to $10.25.</li>
<li>Boston Scientific Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) gained 4.6% to $96.24 after the company announced it entered into a definitive deal to acquire Bold Medical.</li>
<li>UniFirst Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNF#NYSE">UNF</a>) gained 3.7% to $212.25 following upbeat quarterly earnings.</li>
</ul>
Now Read This:
<ul>
<li> <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/01/42873668/jim-cramer-lemonade-is-up-too-much-this-health-care-stock-can-go-lower">Jim Cramer: Lemonade Is &#8216;Up Too Much,&#8217; This Health Care Stock Can Go Lower</a></li>
</ul>

Intraday Update

Movers

ABSI

ADTN

ALTM

ANGO

CALM

EBAY

MATW

SANA

AAR Posts Upbeat Results, Joins AngioDynamics, eBay, Cal-Maine Foods And Other Big Stocks Moving Higher On Wednesday

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.&nbsp; 1. STOCK NEWS: Shares of Domino's Pizza (DPZ) w...

Berkshire reveals stake in Domino's, Alibaba reports mixed Q2: Morning Buzz

Clover Health: Buy The Dip, Reap The Rewards

Health insurers spike as Trump picks Dr. Oz to head Medicare

Trump picks surgeon Marty Makary to head FDA, Rep. Dave Weldon to lead CDC

Alignment Health Plan announced that members enrolled in its HMO plans in Maricopa County now have access to over 4,500 primary care providers, spe...

Alignment Health Plan announces enhanced agreement with Arizona Priority Care

The latest update is out from Alignment Healthcare ( ($ALHC) ). Alignment Healthcare, Inc. has successfully raised $330 million through the sale of...

Alignment Healthcare's Strategic Financial Maneuvers in 2029

Biden administration proposes expanded obesity drug coverage under Medicare, Medicaid

Stephens upgraded Alignment Healthcare (ALHC) to Overweight from Equal Weight with a price target of $17, up from $13. Alignment's competitive adva...

Alignment Healthcare upgraded to Overweight from Equal Weight at Stephens

Unusual total active option classes on open include: Alignment Healthcare (ALHC), Navitas Semiconductor (NVTS), JetBlue (JBLU), AES Corp. (AES), Pl...

Unusually active option classes on open December 4th

Stephens analysts presented the firm's 2025 Best Ideas list, which includes Valley National (VLY), CoStar Group (CSGP), Castle Biosciences (CSTL), ...

Stephens lays out 21 Best Ideas for 2025

ABBV

ALHC

AMAT

AMGN

AMZN

ANDE

ASTS

AVGO

AZTA

BABA

BIIB

BMRC

BPMC

CASI

CGNX

CLOV

CPNG

CSGP

CSTL

CVNA

DESP

GILD

HALO

HIMS

JBLU

MATX

MRNA

NVTS

PRVA

RCAT

ROKU

SEDG

SLGL

SNOW

SNYNF

SSNLF

STKL

TRUG

TWLO

VKTX

WING

Press Releases

Alignment Healthcare Reports Third Quarter 2024 Results

General

Alignment Health Plan Named a "Best" Medicare Advantage Insurer in North Carolina by U.S. News & World Report for Third Consecutive Year

Alignment Health Plan Named a "Best" Medicare Advantage Insurer in Arizona by U.S. News & World Report

Alignment Health Plan Named a "Best" Medicare Advantage Insurer in California by U.S. News & World Report

Alignment Health Plan Named a "Best" Medicare Advantage Insurer in Nevada by U.S. News & World Report

Alignment Healthcare to Present at UBS Global Healthcare Conference and Stephens Annual Investment Conference

Financing

Alignment Healthcare Announces Private Convertible Senior Notes Transaction

Alignment Health Plan Expands Access to Care in Arizona through Enhanced Agreement with Arizona Priority Care

Alignment Healthcare to Present at the 43rd Annual J.P. Morgan Healthcare Conference

UPDATE – Alignment Healthcare to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Comments

Alignment Healthcare

Notizie

Ultime notizie per Alignment Healthcare (NASDAQ:ALHC) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO